View Cart  

Supreme Court Faces Choice on Pay-for-Delay Cases

A A
The FTC Thursday asked the Supreme Court to take up and overturn an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements between branded drug makers and generic competitors.

To View This Article:

Login

Subscribe To Drug Industry Daily